Author

Camilla Folvar

Hackensack Meridian Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:deep learning· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Organism:mouse· 1

Frequent Co-Authors

Matthew ZimmermaniD· 2 shared Alexandra Bozan· 1 shared Amir George· 1 shared Andrew M. Nelson· 1 shared Anthony D. BaughniD· 1 shared Betelhem Tatek· 1 shared Connor W. ColeyiD· 1 shared Courtney C. AldrichiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Matthew ZimmermanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Validating Conditionally Essential Targets: Discovery of the First Orally Effective Biotin Inhibitor against MycobacteriumTuberculosis

Qiang Liu, Joshua B. Wallach, Yahani P. Jayasinghe, Mark R. Sullivan, Julianna Proietto, Suyapa Rodriguez, Stephanie P. Vo, Helena I. Boshoff, Ziyi Jia, Camilla Folvar, Betelhem Tatek, Firat Kaya, Lev Ostrer, Kritee Mehdiratta, Rui Shi, , Courtney C. Aldrich

The paper develops an orally effective biotin inhibitor, C48, against Mycobacterium tuberculosis, demonstrating in vivo efficacy in a low-biotin mouse model.

bioRxiv · Sep 24, 2025 · PreprintMicrobiology

Identification of Antituberculars with Favorable Potency and Pharmacokinetics through Structure-Based and Ligand-Based Modeling

Vedang Warapande, Fanwang Meng, Alexandra Bozan, David Graff, Jenna C. Fromer, Khadija Mughal, Faheem K. Mohideen, Shivangi Shivangi, Sindhuja Paruchuri, Melanie L. Johnston, Pankaj Sharma, Timothy R. Crea, Rudraraju Srilakshmi Reshma, Amir George, Camilla Folvar, , Joel S. Freundlich

The paper develops a hybrid modeling pipeline to identify antitubercular compounds with favorable potency and pharmacokinetics, resulting in 12 promising candidates from a large compound library.

bioRxiv · Feb 3, 2025 · PreprintMicrobiology